Take a trial of UK to unlock this pageFind out more
Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed 4
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Mar 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Last ex-div: 23rd Jul, paid: 22nd Aug more... Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p +9.1%

FINANCIAL BRIEF: For the fiscal year ended 31 March 2014, Immunodiagnostic Systems Hldgs PLC revenues increased 5% to L52.3M. Net income decreased 11% to L7M. Revenues reflect Other segment increase of 23% to L20.7M, Germany segment increase of 29% to L7.1M. Net income was offset by Distribution costs Administrative expens increase of 25% to L10.2M (expense), Impairment of other receivable decrease from L1.5M (income) to L0K. more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score
B+
B+

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Mar '14) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Mar 2015
31st Mar 2016

Price Target: 550 (+15.81% above Price) Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (p) (£) (p) (p)
Consensus Estimate
1m Change
3m Change
4 brokers Broker Consensus Trend
Broker Recommendations for Immunodiagnostic Systems Holdings
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 5 0 1

Named Brokers and Analysts
Investec Bank (UK) Plc Nicholas Keher , Canaccord Genuity Julie Simmonds , Panmure Gordon Savvas Neophytou , N+1 Brewin , Peel Hunt Paul Cuddon , Collins Stewart & Co , Edison Investment Research , Daniel Stewart , N+1 Singer Elizabeth Klein Chris Glasper , FinnCap Keith Redpath ,

Immunodiagnostic Systems Holdings plc (IDS) is engaged in manufacturing and distributing medical diagnostic products. The Company is also involved in research and development projects. The Company’s main operation is within the in vitro diagnostic (IVD) testing industry, supplying test kits to hospital and research laboratories. The Company is also engaged in the provision of immunoassay tests for the determination of vitamin D (both 25-Hydroxy and 1,25-Dihydroxy). The Company’s product include 1,25-Dihydroxy Vitamin D EIA, 1,25-Dihydroxy Vitamin D RIA, 25-Hydroxy Vitamin D EIA, 25-Hydroxy Vitamin D RIA ,Alpha CrossLaps (CTX-I) EIA, Automated IDS-iSYS System, BoneTRAP (TRAcP 5b) ELISA, Corticosterone EIA, Corticosterone HS EIA and CrossLaps for Culture (CTX-I) ELISA.

Directors: Patrik Dahlen (CEO) 52, Christopher Yates (FID) 39, Anthony Martin (NEC) 59, Edward Blair (NID) 54, Roland Sackers (NID) 45,

No. of Employees: 328 No. of Shareholders: 0


Last Annual March 31st, 2014
Last Interim March 31st, 2014
Shares in Issue 29,195,276
Free Float 21.3m (72.8%)
ISIN GB00B01YZ052
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Intl-aim All Share , FTSE Intl-aim 100 ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

IDH Share Price Performance IDH Quote
470p
0.0  0.0%
Traded 2:31pm · Minimum 15 min delayed · NMS: 0.500k

Latest IDH News Announcements (delayed)

Upcoming IDH Events
Tuesday 14th October, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement H1 FY13-14
Tuesday 25th November, 2014
Half Year 2014 Immunodiagnostic Systems Holdings PLC Earnings Release
Tuesday 4th August, 2015 (estimate)
Immunodiagnostic Systems Holdings PLC Annual Shareholders Meeting

Recent ↓
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Annual Shareholders Meeting
Monday 4th August, 2014
Immunodiagnostic Systems Holdings PLC Trading Statement
Wednesday 23rd July, 2014
Dividend For IDH.L
Tuesday 24th June, 2014
Full Year 2013 Immunodiagnostic Systems Holdings PLC Earnings Release
Tuesday 15th April, 2014
Immunodiagnostic Systems Holdings PLC Trading Update for the year ended 31 March 2014
Wednesday 27th November, 2013
Interim 2013 Immunodiagnostic Systems Holdings PLC Earnings Release
Thursday 10th October, 2013
Immunodiagnostic Systems Holdings PLC Trading Update for the six months ended 30 September 2013
Friday 26th July, 2013
Immunodiagnostic Systems Holdings PLC Annual General Meeting
Wednesday 24th July, 2013
Dividend For IDH.L
Monday 17th June, 2013
Preliminary 2012 Immunodiagnostic Systems Holdings PLC Earnings Release


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2014.


Should you buy IDH

Access IDH Analytics Now!

FREE TRIAL or TAKE THE TOUR